^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

BRAF K601E

i
Entrez ID:
Phase 1/2
Memorial Sloan Kettering Cancer Center
Completed
Last update posted :
09/06/2023
Initiation :
02/14/2019
Primary completion :
09/02/2023
Completion :
09/02/2023
BRAF
|
BRAF mutation • BRAF fusion • BRAF K601E • BRAF G469A • BRAF L597Q • BRAF L485W • BRAF T599 • BRAF V600_K601delinsE • BRAF K601 • BRAF L597
|
Mektovi (binimetinib) • Braftovi (encorafenib)
Phase 2
Gustave Roussy, Cancer Campus, Grand Paris
Active, not recruiting
Last update posted :
09/28/2021
Initiation :
12/27/2017
Primary completion :
11/18/2021
Completion :
12/01/2022
KRAS • NRAS • HRAS
|
BRAF V600E • BRAF V600 • HRAS mutation • BRAF K601E • BRAF K601
|
Mekinist (trametinib) • Tafinlar (dabrafenib)